ABBV
AbbVie IncNYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL
Key Statistics
Market Cap
$366.33B
P/E Ratio
87.79
EPS
$2.36
Beta
0.33
52W High
$241.12
52W Low
$159.05
50-Day MA
$222.18
200-Day MA
$215.51
Dividend Yield
3.24%
Profit Margin
6.91%
Forward P/E
14.08
PEG Ratio
0.49
About AbbVie Inc
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Fundamentals
| Revenue (TTM) | $61.16B |
| Gross Profit (TTM) | $43.80B |
| EBITDA | $29.25B |
| Operating Margin | 34.10% |
| Return on Equity | 62.30% |
| Return on Assets | 9.81% |
| Revenue/Share (TTM) | $34.57 |
| Book Value | $-1.85 |
| Price-to-Book | 50.46 |
| Price-to-Sales (TTM) | 5.99 |
| EV/Revenue | 6.95 |
| EV/EBITDA | 24.10 |
| Quarterly Earnings Growth (YoY) | -88.70% |
| Quarterly Revenue Growth (YoY) | 10.00% |
| Shares Outstanding | $1.77B |
| Float | $1.77B |
| % Insiders | 0.11% |
| % Institutions | 76.39% |
Historical Volatility
HV 10-Day
29.31%
HV 20-Day
26.73%
HV 30-Day
26.49%
HV 60-Day
27.53%
HV Rank
57.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($249.14 target)
8
Strong Buy13
Buy9
Hold1
Strong SellData last updated: 3/26/2026